The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019

Biocidal Products (Fees and Charges) Regulations (Northern Ireland) 2015

43.—(1) The Biocidal Products (Fees and Charges) Regulations (Northern Ireland) 2015(1) are amended as follows.

(2) In regulation 2(1), after the definition of “the Executive” insert—

““Regulation 354/2013” means Commission Implementing Regulation (EU) No 354/2013 of 18 April 2013 on changes of biocidal products authorised in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council;

“Regulation 1062/2014” means Commission Delegated Regulation (EU) No 1062/2014 of 4 August 2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council.”

(3) Omit regulation 3.

(4) In regulation 4, for paragraph (1) substitute—

“(1) The Executive shall charge fees for—

(a) work it carries out within the scope of the Biocides Regulation which relates to the activities listed in column 1 of the Table in the Schedule;

(b) work it carries out in order to evaluate an application for a change to an authorised product under Regulation 354/2013;

(c) work it carries out in order to determine an application to be a participant for the review of an active substance/product-type combination under Article 17 of Regulation 1062/2014; and

(d) work it carries out in order to evaluate an application under regulation 12 of the Biocidal Products and Chemicals (Appointment of Authorities and Enforcement) Regulations (Northern Ireland) 2013(2).”

(5) In the Schedule, for the table substitute—

“Table

1 Activity	2 Fee per person per day worked
(a) Validation of an application for approval of an active substance	£447
(b) Evaluation of an application to approve an active substance	£447
(c) Evaluation of an application to renew an active substance approval	£447
(d) Validation of an application to amend the conditions of approval of an active substance	£447
(e) Evaluation of an application to amend the conditions of approval of an active substance	£447
(f) Work relating to a request for inclusion of an active substance in the Simplified Active Substance List made on behalf of an economic operator	£447
(g) Validation of an application to amend the conditions of inclusion of an active substance in the Simplified Active Substance List	£447
(h) Evaluation of an application to amend the conditions of inclusion of an active substance in the Simplified Active Substance List	£447
(i) Meetings with applicants and prospective applicants	£447
(j) Evaluation of an application to authorise a biocidal product under the simplified procedure	£393
(k) Validation of an application for a national authorisation of a biocidal product	£393
(l) Evaluation of an application for a national authorisation of a biocidal product	£393
(m) Evaluation of an application to renew a national authorisation of a biocidal product	£393
(n) Determination of an application to amend an existing biocidal product authorisation	£393
(o) Evaluation of an application for an emergency use permit	£393
(p) Assessment of an application to be included in the list of suppliers maintained under Article 95 of Regulation 528/2012	£447
(q) Determination of a request that information on an active substance or product is not made publicly available	£447
(r) Determination of the classification of a proposed change to an authorised product in accordance with Regulation 354/2013	£393
(s) Determination of an application to be a participant for the review of an active substance/product-type combination under Article 17 of Regulation 1062/2014	£447
(t) Assessment of technical equivalence	£447
(u) Evaluation of an application under regulation 12 of the Biocidal Products and Chemicals (Appointment of Authorities and Enforcement) Regulations (Northern Ireland) 2013	£393”

(1)

S.R. 2015 No. 254

(2)

S.R. 2013 No. 206.